Prolocor(R) Announces Publication in Circulation: Cardiovascular Interventions. Results Demonstrate That the Prolocor pFCG(TM) Test Predicts Risk of Subsequent Cardiovascular Events Regardless of Treatment Strategy (Percutaneous Coronary Intervention or Medical Management Alone)
PHILADELPHIA, March 28, 2025 (Ecnetnews.com) - Prolocor, Inc., a healthcare startup developing the innovative diagnostic Prolocor pFCGTM test that identifies ...